Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Braz Oral Res ; 38: e043, 2024.
Article in English | MEDLINE | ID: mdl-38747830

ABSTRACT

This cross-sectional study evaluated the association between salivary immunoglobulins, plaque index, and gingival index in Brazilian children with and without type 1 diabetes mellitus (DM1). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for the reporting of observational studies was followed. The DM1 group had 38 children, and an equal number of volunteers matched by sex and age were recruited as controls. Clinical examination was performed for plaque index and gingival index determination. Non-stimulated whole saliva was collected. Concentrations of IgA, IgG, and IgM were determined by ELISA test. Data were tested by the Kolmogorov-Smirnov, Mann-Whitney, and Spearman tests and a multiple linear regression model (p<0.05) was performed. Gingival index was higher in the Control (DM1: 0.16±0.17; Control: 0.24±0.23, p=0.040). In DM1, there was a correlation between IgA and age (rho=0.371, p=0.024), IgM and IgG (rho=0.459, p=0.007), and IgM and gingival index (rho=0.394, p=0.014). In DM1, multiple linear regression showed that age (p=0.041; ß=0.363), gingival index (p=0.041; ß=0.398), and plaque index (p=0.008; ß=-0.506) were good predictors of IgA levels in saliva. Thus, IgA was the only researched immunoglobulin that was directly associated with plaque and gingival indices in Brazilian children with DM1, but not in control subjects.


Subject(s)
Dental Plaque Index , Diabetes Mellitus, Type 1 , Immunoglobulin A , Periodontal Index , Saliva , Humans , Diabetes Mellitus, Type 1/immunology , Male , Female , Saliva/chemistry , Saliva/immunology , Cross-Sectional Studies , Child , Brazil/epidemiology , Case-Control Studies , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Statistics, Nonparametric , Immunoglobulin M/analysis , Reference Values , Enzyme-Linked Immunosorbent Assay , Adolescent , Linear Models , Age Factors , Immunoglobulins/analysis
2.
Res Vet Sci ; 161: 163-172, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37406575

ABSTRACT

Endothelial dysfunction is an early complication of diabetes and it is related to both micro- and macroangiopathies. In addition, >70% of diabetic patients develop autonomic neuropathies. Increased oxidative stress has a major role in the development of both nitrergic and endothelial dysfunction. The aim of this work is to evaluate whether rutin, a potent antioxidant, could ameliorate nitrergic and/or endothelial dysfunction in diabetic animals. Primary and secondary treatment protocols with rutin were investigated on rat aortic rings and the mesenteric arteriolar bed, and on rabbit aortic rings and corpora cavernosa (RbCC) from both euglycemic and alloxan-diabetic animals. Acetylcholine endothelium-dependent and sodium nitroprusside endothelium-independent relaxations were compared in tissues from euglycemic or diabetic animals. Electrical field stimulation (EFS)-induced relaxation was performed only in the RbCC. Endothelial-dependent relaxations were blunted by 40% in vessels and neuronal relaxation was blunted by 50% in RbCC taken from diabetic animals when compared to euglycemic animals. Pre-treatment with rutin restored both neuronal and endothelial dependent relaxations in diabetic animals towards the values achieved in control euglycemic tissues. Rutin was able to ameliorate both endothelial dysfunction and nitrergic neuropathy in animal experimental models. Rutin could be a lead compound in the primary or secondary preventive ancillary treatment of endothelial and nitrergic dysfunction in the course of diabetes.


Subject(s)
Diabetes Mellitus , Male , Rats , Animals , Rabbits , Rutin/pharmacology , Rutin/therapeutic use , Penis , Nitroprusside/pharmacology , Acetylcholine/pharmacology , Endothelium, Vascular , Diabetes Mellitus/veterinary , Nitric Oxide
3.
Eur J Pharmacol ; 880: 173130, 2020 Aug 05.
Article in English | MEDLINE | ID: mdl-32360975

ABSTRACT

Pinitol is a natural antidiabetic agent shown to prevent or ameliorate metabolic and overall vascular and neural function. In the present study we have evaluated the potential benefits of pinitol on renal function of streptozotocin (STZ)-induced diabetic rats. Both euglycemic or 8-week or 16-week diabetic rats were treated with either saline (1 ml/kg/12h; p.o) or pinitol (20 mg/kg/12h; p.o). The renal function was evaluated by using metabolic cages, renal hemodynamic and tubular parameters measurements. Histological examination and evaluation of the protein expression of renal markers such as nephrin, TGFß and pERK were also performed. Pinitol decreased by 50% the increased urinary albumin/creatinine ratio in both 8-week and 16 week diabetic rats. In addition, the glomerular volume of 16-week rats increased by 55% and this increase was blunted by pinitol. Remarkably, pressure-natriuresis was completely blunted in both 8 and 16-week diabetic rats but this impairment was prevented by pinitol in both treatment regimens. Pinitol ameliorated renal lesions and also prevented the decrease in nephrin expression and the increase of pERK and TGFß expression in both diabetic groups. Natriuresis due to high renal perfusion pressure increased 7-fold in control animals but was blocked in 16-week diabetic rats and remarkably pinitol partially restored pressure natriuresis (3-fold increase in sodium excretion during pressure natriuresis). Pinitol prevents and ameliorates albuminuria, glomerular expansion, impairment of pressure-natriuresis, renal structural alterations and changes of renal markers and has the potential to be tested for the prevention of diabetic kidney disease.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Inositol/analogs & derivatives , Kidney/drug effects , Protective Agents/therapeutic use , Albuminuria/drug therapy , Albuminuria/metabolism , Albuminuria/pathology , Albuminuria/physiopathology , Animals , Creatinine/urine , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Experimental/physiopathology , Extracellular Signal-Regulated MAP Kinases/metabolism , Hemodynamics , Hypoglycemic Agents/pharmacology , Inositol/pharmacology , Inositol/therapeutic use , Kidney/pathology , Kidney/physiology , Male , Membrane Proteins/metabolism , Protective Agents/pharmacology , Rats, Wistar , Transforming Growth Factor beta/metabolism
4.
Res Vet Sci ; 130: 153-160, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32193002

ABSTRACT

The aim of this study was to investigate the antihypertensive properties of cis-[Ru(bpy)2ImN(NO)]3+ (FOR0811) in normotensive and in Nω-nitro-L-arginine methyl ester (L-NAME)-induced hypertensive rats. Vasorelaxant effects were analyzed by performing concentration response curve to FOR0811 in rat aortic rings in the absence or presence of 1H-[1,2,4]-oxadiazolo-[4,3,-a]quinoxalin-1-one (ODQ), L-cysteine or hydroxocobalamin. Normotensive and L-NAME-hypertensive rats were treated with FOR0811 and the effects in blood pressure and heart rate variability in the frequency domain (HRV) were followed. FOR0811 induced relaxation in rat aortic rings. Neither endothelium removal nor L-cysteine altered the FOR0811 effects. However, the incubation with ODQ and hydroxocobalamin completely blunted FOR0811 effects. FOR0811 administered intravenously by bolus infusion (0.01-1 mg/bolus) or chronically by using subcutaneous implanted osmotic pumps significantly reduced the mean arterial blood pressure. The effect was long lasting and did not induce reflex tachycardia. FOR0811 prevented both LF and VLF increases in L-NAME hypertensive rats and has antihypertensive properties. This new ruthenium complex compound might be a promising nitric oxide donor to treat cardiovascular diseases.


Subject(s)
Antihypertensive Agents/pharmacology , Hypertension/drug therapy , Nitric Oxide Donors/pharmacology , Organometallic Compounds/pharmacology , Ruthenium/pharmacology , Vasodilator Agents/pharmacology , Animals , Blood Pressure/drug effects , Heart Rate/drug effects , Hypertension/chemically induced , Male , NG-Nitroarginine Methyl Ester/administration & dosage , Rats , Rats, Wistar
5.
Acta Trop ; 192: 61-65, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30689977

ABSTRACT

Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania. There are many complications presented by the current treatment, as high toxicity, high cost and parasite resistance, making the development of new therapeutic agents indispensable. The present study aims to evaluate the leishmanicidal potential of ruthenium nitrosyl complex cis-[Ru(bpy)2(SO3)(NO)](PF6) against Leishmania (Viannia) braziliensis. The effect of this metal complex on parasite-host interaction was evaluated by in vitro efficacy test in dermal fibrobast cells in the presence of different concentrations (1, 10, 50 and 100 µM) and by in vivo efficacy tests performed in the presence of two different concentrations of complex (100 µg/kg/day or 300 µg/kg/day) evaluating its effect on the size of the lesion and the number of parasites present in the draining lymph nodes in hamsters. Even at the lowest concentration of 1 µM of ruthenium complex, it was observed a significant decrease of the infected cells, after 24 h exposure in vitro, with total reduction at 50 µM of the ruthenium complex. In the in vivo cutaneous infection model, administration of daily doses of 300 µg/kg/day of complex reduced significantly lesion size by 51% (p < 0.05), with a 99.9% elimination of the parasites found in the lymph nodes (p < 0.001). The results suggest a promising leishmanicidal effect by that ruthenium nitrosyl complex against L. (V.) braziliensis.


Subject(s)
Leishmania braziliensis/drug effects , Ruthenium Compounds/pharmacology , Animals , Cricetinae , Dose-Response Relationship, Drug , Host-Parasite Interactions , Skin
6.
Eur J Pharmacol ; 833: 425-431, 2018 Aug 15.
Article in English | MEDLINE | ID: mdl-29913125

ABSTRACT

The purpose of this study was to evaluate in vitro the effect of the combination of BRL 37344 (ß3-adrenoceptor agonist) with tadalafil (phosphodiesterase type 5 inhibitor) or rolipram (phosphodiesterase type 4 inhibitor) in an experimental model of detrusor overactivity. The experiments were carried out in two phases using bladder strips of mice. In the first phase, on the top of 40 mM potassium-induced contraction, strips isolated from control mice were exposed to increasing concentrations of each study drug. In another series of experiments, prior to contraction, strips were incubated with either tadalafil or rolipram, followed by the addition of increasing concentrations of BRL 37344. In the second phase, the same protocols were performed with animals previously treated with L-NAME for 30 days. Chronic L-NAME administration leads to detrusor overactivity due to nitric oxide synthase inhibition. In phase one, preincubation with tadalafil enhanced relaxation response to BRL 37344 at two concentrations. Pretreatment with rolipram had no effect on BRL 37344-induced relaxation. In L-NAME-treated mice, rolipram induced more relaxation than the other drugs, enhancing relaxation response to BRL 37344 at almost all concentrations, but no synergistic effect with tadalafil was observed. The relaxant effect of BRL 37344 was enhanced by rolipram but not by tadalafil, suggesting that PDE4 inhibition, especially when associated with ß3-adrenoceptor stimulation, could represent a potential treatment for overactive bladder.


Subject(s)
Adrenergic beta-3 Receptor Agonists/pharmacology , Phosphodiesterase 4 Inhibitors/pharmacology , Phosphodiesterase 5 Inhibitors/pharmacology , Urinary Bladder, Overactive/drug therapy , Adrenergic beta-3 Receptor Agonists/therapeutic use , Animals , Disease Models, Animal , Drug Evaluation, Preclinical , Drug Synergism , Drug Therapy, Combination/methods , Ethanolamines/pharmacology , Ethanolamines/therapeutic use , Humans , Male , Mice , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Muscle, Smooth/physiopathology , NG-Nitroarginine Methyl Ester/toxicity , Phosphodiesterase 4 Inhibitors/therapeutic use , Phosphodiesterase 5 Inhibitors/therapeutic use , Rolipram/pharmacology , Rolipram/therapeutic use , Tadalafil/pharmacology , Tadalafil/therapeutic use , Treatment Outcome , Urinary Bladder/drug effects , Urinary Bladder/physiopathology , Urinary Bladder, Overactive/chemically induced , Urinary Bladder, Overactive/physiopathology
7.
Life Sci ; 112(1-2): 74-81, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25084123

ABSTRACT

AIMS: The effects of the essential oil of Croton zehntneri (EOCz) and its major components anethole, estragole and methyl eugenol were evaluated in phenylephrine precontracted rat corpora cavernosa (RCC). MAIN METHODS: RCC strips were mounted in 5 ml organ baths for isometric recordings of tension, precontracted with 10 µM phenylephrine and exposed to test drugs. KEY FINDINGS: All major compounds relaxed RCC. The order of potency was estragole>anethole>methyl eugenol. The maximal relaxation to EOCz and methyl eugenol was 62.67% (IC50 of 1.67 µM) and 45.8% (IC50 of 1.7 µM), respectively. Estragole relaxed RCC with an IC50 of 0.6 µM (maximal relaxation-76.6%). The maximal relaxation to estragole was significantly reduced by L-NAME (43.46%-IC50 of 1.4 µM), ODQ (53.11%-IC50 of 0.83 µM) and indomethacin (24.41%-IC50 of 1.3 µM). On the other hand, anethole relaxed RCC by 66.73% (IC50 of 0.96 µM) and this relaxation was blunted by indomethacin (35.65%-IC50 of 1.6 µM). Both estragole and anethole increased the relaxation achieved upon electrical stimulation. Both compounds increased the levels of cAMP (estragole by 3-fold and anethole by 2-fold when compared to controls). Estragole also increased the levels of cGMP (0.5-fold). SIGNIFICANCE: The higher potency of these compounds to relax corpora cavernosa smooth muscle may form the pharmacological basis for the use of such substances as leading compounds in the search of alternative treatments of erectile dysfunction.


Subject(s)
Anisoles/pharmacology , Croton Oil/chemistry , Croton/chemistry , Isometric Contraction/drug effects , Muscle, Smooth/drug effects , Urological Agents/pharmacology , Allylbenzene Derivatives , Animals , Colforsin/pharmacology , Croton Oil/pharmacology , Cyclic AMP/metabolism , Cyclic GMP/metabolism , Male , Muscle Relaxation/drug effects , Muscle, Smooth/physiology , Nitric Oxide/metabolism , Penis/drug effects , Penis/physiology , Phenylephrine/pharmacology , Piperazines/pharmacology , Plant Extracts/chemistry , Purines/pharmacology , Rats , Rats, Wistar , Sildenafil Citrate , Sulfones/pharmacology , Tissue Culture Techniques
8.
Fundam Clin Pharmacol ; 27(2): 201-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-21895762

ABSTRACT

The objective of this study was to evaluate the antinociceptive effects of a lectin from Canavalia brasiliensis (ConBr) when administered orally to murine models of chemical and thermal nociception. ConBr up to 100 mg/kg produced significant and dose-dependent antinociceptive effects: 81% reduction in abdominal writhing induced by 0.6% acetic acid; 26 and 52% reduction in early- and late-stage paw licking, respectively, induced by 2.5% formalin; and 155% increase in reaction latency (heightened thermal pain threshold). In all models, the antinociceptive effect was reversed by the lectin-binding carbohydrate α-d-methyl-mannoside and by the nonselective opioid antagonist naloxone. The antinociceptive effect observed in the formalin test was inhibited by the δ-selective antagonist naltrindole and the κ-selective antagonist nor-binaltorphimine but not by the µ-selective antagonist cyprodime. In conclusion, when administered orally to Swiss mice, the ConBr lectin displayed antinociceptive activity, both peripheral and central, mediated by the opioid system and involving δ-and κ-receptors and the lectin domain.


Subject(s)
Analgesics, Opioid/pharmacology , Analgesics/pharmacology , Canavalia/chemistry , Nociception/drug effects , Plant Lectins/pharmacology , Administration, Oral , Analgesics/isolation & purification , Analgesics, Opioid/isolation & purification , Animals , Mice , Morphinans/pharmacology , Naloxone/pharmacology , Naltrexone/analogs & derivatives , Naltrexone/pharmacology , Pain Measurement/methods , Plant Lectins/chemistry , Plant Lectins/isolation & purification , Receptors, Opioid, delta/antagonists & inhibitors , Receptors, Opioid, kappa/antagonists & inhibitors , Seeds/chemistry
9.
Nat Prod Commun ; 8(11): 1621-4, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24427956

ABSTRACT

Canavalia gladiata (CGL), C. maritima (ConM) and C. brasiliensis (ConBr) lectins were evaluated in nociception models. ConBr inhibited first (32%) and second (100%) phases of the formalin test; CGL inhibited only the first (74%) and ConM only the second (59%) phase. Hypernociception evaluated in the Von Frey test was inhibited by ConM (55%), CGL (41%) and ConBr (38%). Acetic acid-induced abdominal writhing was reduced by ConBr (66%), CGL (52%) and ConM (60%). ConBr and CGL effects were reversed by the lectin association with its ligand sugar. The antinociceptive activity of the structural homologous lectins was differentiated by potency, efficacy and mechanisms.


Subject(s)
Analgesics/pharmacology , Plant Lectins/pharmacology , Animals , Male , Mice , Motor Activity/drug effects
10.
Nutrition ; 28(7-8): 744-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22541058

ABSTRACT

OBJECTIVE: The aim of the present study was to investigate the protein profile of children with different levels of protein-energy undernutrition (PEU) through a proteomic approach of human whole saliva. METHODS: Initially, saliva samples of children with mild, moderate, and severe PEU were collected and lyophilized. Saliva samples of healthy children were used as controls. Samples were analyzed for total protein using the Bradford method. Saliva samples were analyzed by two-dimensional electrophoresis according to their isoelectric point (pI) and their molecular weights (MWs). RESULTS: Comparisons of protein bands among the healthy and mildly, moderately, and severely undernourished children showed significant differences in the MWs (P = 0.001) and pI values (P = 0.03). In total 159 spots were identified in the healthy children; 156, 168, and 221 spots were observed in mildly, moderately, and severely undernourished children, respectively. Mildly undernourished children presented with the spot with the highest MW of 293 kDa (pI = 7.77) and the lowest MW of 5 kDa (pI = 4.83). Moderately undernourished children were the only ones who did not present with a protein band with an MW of 30 kDa. The presence of a protein band with an MW of 123 kDa (pI = 516), possibly a cyclin-dependent protein kinase, was also observed only in this group. CONCLUSION: The protein profile in saliva varies according to the presence or absence of PEU, and these variations are specifically expressed in different grades of undernutrition. Thus, saliva may be an important diagnostic tool for the assessment of PEU.


Subject(s)
Nutrition Assessment , Protein-Energy Malnutrition/diagnosis , Protein-Energy Malnutrition/metabolism , Saliva/metabolism , Salivary Proteins and Peptides/metabolism , Child , Child, Preschool , Cyclin-Dependent Kinases/chemistry , Cyclin-Dependent Kinases/metabolism , Databases, Protein , Electrophoresis, Gel, Two-Dimensional , Female , Freeze Drying , Humans , Infant , Isoelectric Point , Male , Molecular Weight , Protein-Energy Malnutrition/physiopathology , Proteomics/methods , Salivary Proteins and Peptides/chemistry , Severity of Illness Index
11.
J Appl Toxicol ; 31(8): 720-9, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21319174

ABSTRACT

Phyllorhiza punctata (P. punctata) is a jellyfish native to the southwestern Pacific. Herewith we present the biochemical and pharmacological characterization of an extract of the tentacles of P. punctata. The tentacles were subjected to three freeze-thaw cycles, homogenized, ultrafiltered, precipitated, centrifuged and lyophilized to obtain a crude extract (PHY-N). Paralytic shellfish poisoning compounds such as saxitoxin, gonyautoxin-4, tetrodotoxin and brevetoxin-2, as well as several secretory phospholipase A(2) were identified. PHY-N was tested on autonomic and somatic neuromuscular preparations. In mouse vas deferens, PHY-N induced phasic contractions that reached a peak of 234 ± 34.7% of control twitch height, which were blocked with either 100 µ m of phentolamine or 1 m m of lidocaine. In mouse corpora cavernosa, PHY-N evoked a relaxation response, which was blocked with either L-N(G) -Nitroarginine methyl ester (0.5 m m) or 1 m m of lidocaine. PHY-N (1, 3 and 10 µg ml(-1) ) induced an increase in tonus of the biventer-cervicis neuromuscular preparation that was blocked with pre-treatment of galamine (10 µ m). Administration of 6 mg kg(-1) PHY-N intramuscularly produced death in broilers by spastic paralysis. In conclusion, PHY-N induces nerve depolarization and nonspecifically increases neurotransmitter release.


Subject(s)
Cnidarian Venoms/toxicity , Neuromuscular Junction/drug effects , Scyphozoa/chemistry , Synaptic Transmission/drug effects , Animals , Chickens , Cnidarian Venoms/isolation & purification , Lidocaine/metabolism , Male , Marine Toxins , Mice , Neuromuscular Junction/metabolism , Oxocins/isolation & purification , Oxocins/toxicity , Phentolamine/metabolism , Phospholipases A2/isolation & purification , Phospholipases A2/toxicity , Saxitoxin/analogs & derivatives , Saxitoxin/isolation & purification , Saxitoxin/toxicity , Specimen Handling , Tetrodotoxin/isolation & purification , Tetrodotoxin/toxicity , Vas Deferens/drug effects
12.
J Pharm Pharmacol ; 61(3): 361-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19222909

ABSTRACT

OBJECTIVES: 1,8-Cineole is a monoterpene with anti-inflammatory, vascular and intestinal smooth muscle relaxant activity. We have evaluated the potential bronchodilatatory activity of this compound. METHODS: 1,8-Cineole was tested against carbachol, histamine, K+ 80 mM and ovalbumin-induced bronchial contractions in Wistar rat or guinea-pig tissues. Some of the guinea-pigs had been previously sensitized with an intramuscular injection of 5% (w/v) ovalbumin/saline solution. Control animals received 0.3 ml saline. In separate experimental groups the response to 1,8-cineole (1-30 mg/kg), phenoterol (0.05-5 mg/kg) or vehicle (0.3% Tween in saline) was studied. KEY FINDINGS: 1,8-Cineole decreased, in vivo, rat bronchial resistance with similar efficacy as phenoterol (66.7 +/- 3.2% vs 72.1 +/- 5.3%). On the other hand, the maximal relaxant response to 1,8-cineole in carbachol-precontracted rat tracheas was 85.5 +/- 5.7% (IC50 = 408.9 (328-5196) microg/ml) compared with 80.2 +/- 4.8% (IC50 = 5.1 (4.3-6.1) microg/ml) with phenoterol. The addition of 1,8-cineole to guinea-pig tracheal rings tonically contracted with K+ 80 mM induced a concentration-related relaxation. The maximal relaxation elicited by 1,8-cineole was 113.6 +/- 11.7% (IC50 127.0 (115.9-139.2) microg/ml) compared with 129.7 +/- 14.6% (IC50 0.13 (0.12-0.14) microg/ml) achieved after phenoterol administration. In addition, the incubation of tracheal rings with 1,8-cineole (100, 300 or 1000 microg/ml), 15 min before inducing phasic contractions with K+ 80 mM, decreased the maximal amplitude of the contraction by 31.6 +/- 4.6, 75.7 +/- 2.7 and 92.2 +/- 1.5%, respectively. In another set of experiments, neither the maximal response nor the IC50 for the 1,8-cineole-induced relaxation were different between normal and ovalbumin-sensitized tissues. Moreover, the relaxation of bronchial rings contracted after exposure to 1 microg/ml ovalbumin occurred at a faster rate in rings pre-incubated with 1,8-cineole when compared with rings pre-incubated with vehicle only (Tween 0.3%). Therefore, in the first minute after the antigen challenge, the tracheal tissue relaxed after the peak contraction by 6.5, 21.4 (P < 0.05 vs control) and 66.9% (P < 0.05 vs control) in the presence of 100, 300 or 1000 microg/ml 1,8-cineole, respectively. CONCLUSIONS: 1,8-Cineole relaxed rat and guinea-pig (nonsensitized and ovalbumin-sensitized) airway smooth muscle by a nonspecific mechanism.


Subject(s)
Bronchodilator Agents/pharmacology , Cyclohexanols/pharmacology , Monoterpenes/pharmacology , Muscle Relaxation/drug effects , Muscle, Smooth/drug effects , Animals , Bronchi/drug effects , Bronchi/metabolism , Bronchodilator Agents/administration & dosage , Cyclohexanols/administration & dosage , Disease Models, Animal , Dose-Response Relationship, Drug , Eucalyptol , Female , Fenoterol/administration & dosage , Fenoterol/pharmacology , Guinea Pigs , Inhibitory Concentration 50 , Male , Monoterpenes/administration & dosage , Muscle, Smooth/metabolism , Ovalbumin , Rats , Rats, Wistar , Trachea/drug effects , Trachea/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...